This "Specialty Testing" webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded by transitioning lab spaces, reassigning staff, and fast-tracking funding approvals.
Dr. Theel, director, Mayo Clinic Infectious Diseases Serology Laboratory, was recently highlighted in the Star Tribune's special issue featuring heroes of the pandemic.
Matthew Binnicker, Ph.D., Director of Clinical Virology at Mayo Clinic, was recently featured in an interview with Fox News on the COVID-19 infection.
Matthew Binnicker, Ph.D., discusses the need for laboratory testing for the diagnosis and management of fast-spreading viral infections.
Jane Hermansen, MT(ASCP), was recently featured in 360Dx discussing new federal regulations aimed at hospital price transparency.
Rondell Graham, M.B.B.S., an anatomic and molecular consultant at Mayo Clinic, co-led a molecular oncology tumor board session at CAP19, and subsequently spoke with CAP Today.
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, Co-Director of the Vector-Borne Diseases Laboratory, and Associate Professor of Laboratory Medicine and Pathology, was recently interviewed by CAP Today about new Lyme disease testing.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide. Rapid and accurate identification of the infection enables directed monitoring of patients who may be at increased risk of developing hemorrhagic fever of dengue shock syndrome.
Leading the charge to help educate and find solutions to the antimicrobial resistance crisis is Robin Patel, M.D., as she recently served on a congressional briefing panel.
Jane Hermansen, Manager, Outreach and Network Development, is featured on the cover of October’s MedicalLab Management where she takes a good look at lessons to be learned from Theranos.
The purpose of the panel was to provide insight into how some health care systems are paving the way for value-based care.
Matthew Binnicker, Ph.D., Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic, recently spoke with Consultant360 regarding testing for viral gastroenteritis.